blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2345423

EP2345423 - ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.03.2015
Database last updated on 27.07.2024
Most recent event   Tooltip06.03.2015Application deemed to be withdrawnpublished on 08.04.2015  [2015/15]
Applicant(s)For all designated states
Proyecto de Biomedicina Cima, S.L.
Avda. Pío XII, 22 Oficina 1
31008 Pamplona - Navarra / ES
[2011/29]
Inventor(s)01 / ALDABE ARREGUI, Rafael
Ict (d.p.i.) Avda. Pío XII 53
E-31008 Pamplona - Navarra / ES
02 / GONZÁLEZ DE LA TAJADA, Iranzu
Ict (d.p.i.) Avda. Pío XII 53
E-31008 Pamplona - Navarra / ES
03 / LARREA LEOZ, María Esther
Ict (d.p.i.) Avda. Pío XII 53
E-31008 Pamplona - Navarra / ES
04 / PRIETO VALTUEÑA, Jesús María
Ict (d.p.i.) Avda. Pío XII 53
E-31008 Pamplona - Navarra / ES
05 / SAROBE UGARRIZA, Pablo
Ict (d.p.i.) Avda. Pío XII 53
E-31008 Pamplona - Navarra / ES
 [2011/29]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2011/29]ABG Patentes, S.L.
Avenida de Burgos 16D Edificio Euromor
28036 Madrid / ES
Application number, filing date09755922.306.10.2009
[2011/29]
WO2009ES70419
Priority number, dateES2008000283507.10.2008         Original published format: ES 200802835
[2011/29]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010040882
Date:15.04.2010
Language:ES
[2010/15]
Type: A1 Application with search report 
No.:EP2345423
Date:20.07.2011
Language:EN
[2011/29]
Search report(s)International search report - published on:EP15.04.2010
ClassificationIPC:A61K39/39, C12N5/0783, A61K35/14, A61K38/19
[2011/29]
CPC:
A61K39/39 (EP,US); A61K38/19 (ES); A61K38/204 (EP,US);
A61K38/21 (EP,US); A61P31/04 (EP); A61P31/10 (EP);
A61P33/00 (EP); A61P35/00 (EP); A61P37/04 (EP);
A61K2039/5158 (EP,ES,US); A61K2039/55522 (EP,US); A61K2039/57 (EP,US) (-)
C-Set:
A61K38/204, A61K2300/00 (US,EP);
A61K38/21, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/29]
Extension statesAL06.05.2011
BA06.05.2011
RS06.05.2011
TitleGerman:ONCOSTATIN M ALS MITTEL ZUR FÖRDERUNG DER IMMUNSTIMULIERENDEN WIRKUNG VON MENSCHLICHEN EPITHELZELLEN[2011/29]
English:ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS[2011/29]
French:ONCOSTATINE M UTILISÉE COMME POTENTIALISATEUR DE L'ACTIVITÉ IMMUNOSTIMULATRICE DE CELLULES ÉPITHÉLIALES HUMAINES[2011/29]
Entry into regional phase06.05.2011Translation filed 
06.05.2011National basic fee paid 
06.05.2011Designation fee(s) paid 
06.05.2011Examination fee paid 
Examination procedure06.08.2010Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.05.2011Amendment by applicant (claims and/or description)
06.05.2011Examination requested  [2011/29]
31.07.2012Despatch of a communication from the examining division (Time limit: M06)
11.02.2013Reply to a communication from the examining division
26.06.2014Despatch of a communication from the examining division (Time limit: M04)
07.11.2014Application deemed to be withdrawn, date of legal effect  [2015/15]
03.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/15]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.07.2012
Fees paidRenewal fee
04.10.2011Renewal fee patent year 03
05.10.2012Renewal fee patent year 04
28.10.2013Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.201406   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2002119121  (VITIELLO MARIA ANTONELLA [US], et al) [X] 16-20 * example - *;
 [AD]JP2004026768  (KANAGAWA KAGAKU GIJUTSU AKAD) [AD] 1-21 * the whole document *;
 [X]WO2004053113  (ORDER SISTERS OF MERCY QUEENSL [AU], et al) [X] 16-20 * example - *;
 [XD]EP1905447  (PROYECTO BIOMEDICINA CIMA SL [ES]) [XD] 1-13 * paragraphs [0009] , [0 19] , [0 20] , [0 34] , [0 43] , [0 43] , [0 47] , [0 58] , [0 59] , [0 61] , [0 62] *;
 [XP]  - LARREA E ET AL, "Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells.", JOURNAL OF VIROLOGY, (200904), vol. 83, no. 7, ISSN 1098-5514, pages 3298 - 3311, XP002565385 [XP] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.02167-08
by applicantUS4530901
 US4695623
 US4897471
 EP0422186
 JP2004026768
 WO2006084092
 EP1905447
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.